Sign In
Buy DFFN
$5.87
+0 (+0%)
At Close: Nov 28, 2023
Material Processing Institute at forefront of £10m innovation project
02:38pm, Monday, 08'th Jun 2020
The Middlesbrough business is playing a leading role in the project, which involves four other firms
200 jobs at risk at Scunthorpe soup and sauce manufacturer
02:10pm, Friday, 05'th Jun 2020
TSC Foods is heavily reliant on the foodservice sector and has reported a 75 per cent drop in business
200 jobs to go at food factory as a result of coronavirus outbreak
11:14am, Friday, 05'th Jun 2020
Here's the latest
Huge jobs blow as TSC Foods factory to axe up to 200 staff
06:00am, Friday, 05'th Jun 2020
TSC Foods in Scunthorpe says it has seen a 75 per cent decline in business as a result of the crisis
Aurinia Presents AURORA Pivotal Trial Subgroup Analysis at the EULAR 2020 E-Congress
12:00am, Friday, 05'th Jun 2020
Aurinia Pharmaceuticals Inc. (Nasdaq:AUPH / TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancin
Houston drill pipe manufacturer may layoff entire workforce amid oil bust
06:30pm, Thursday, 04'th Jun 2020
Texas Steel Conversion said it might cut all of its employees — nearly 500 people — due to the oil bust sparked by the coronavirus.
Diffusion Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price Requirement
12:00pm, Monday, 01'st Jun 2020
The Company had previously been notified by Nasdaq on December 11, 2019 that it was not in compliance with the minimum bid price rule because its common stock failed to maintain a minimum bid price of
2020 Settings of React TypeScript Project with webpack and Babel
10:02am, Sunday, 31'st May 2020
With create-react-app, you can properly and super easily setup a React TypeScript project. But what if you predict your application…
GW Pharma: Analysts Aren't Thinking Clearly (NASDAQ:GWPH)
11:00am, Thursday, 28'th May 2020
Analysts may have it wrong on GWPH revenues. A warehousing effect ex-US may have flattered revenues, but that doesn't mean Q2'20 will be a weak quarter. US Epid
Diffusion Pharmaceuticals Receives Accelerated FDA Response to Proposed TSC COVID-19 Clinical Trial Program
12:00pm, Tuesday, 26'th May 2020
The PIND was filed on April 27, seeking FDA guidance on the Company’s proposed clinical development program for the use of trans sodium crocetinate (TSC) in COVID-19 patients displaying severe respi
CEL-SCI: What's Next (NYSEMKT:CVM)
01:40am, Tuesday, 26'th May 2020
Phase III trial recently ended. Top line data results very soon. SEER data points to success. Price target $200 upon approval.
10 at 10: These 10 ASX stocks are gliding through the skies this morning - Stockhead
12:17am, Tuesday, 26'th May 2020
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in perc
Aurinia Pharmaceuticals Inc. (Nasdaq:AUPH / TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancin
Cel-Sci: A Zombie Biotech Company (NYSEMKT:CVM)
01:00pm, Saturday, 23'rd May 2020
Cel-Sci has been dragging a drug trial on for years which should have been stopped in 2014 on the recommendation of their Independent Data Monitoring Committee.
